Halberd Corp (HALB)

[EHRjunkie]

Yesterday Halberd published research results about their two patent-pending monoclonal antibodies that have demonstrated strong affinity and neutralizing capabilities against three of the identified SARS-CoV-2 mutations. The principal researcher, Dr. Shawn Chen (ASU and GreenbioAZ inc), indicated that Halberd's two monoclonal antibodies have been successfully tested against the Q498Y, P499T and Q493K SARS-2 variants.

Now if anything they claim is BS, the SEC would shut HALB down immediately, like they did with dozens of fraudulent companies. Well, they don't.

Would be nice if people posting here stick to the facts.